California Biotech

California's biotech & life science industry leads the world in life-saving cures for diseases that impact global communities.

[California Biotech @CABiotech]

Proud to celebrate this milestone 🎉 Thank you to @SenBlakespear and the Legislature for recognizing 20 years of CBF and 50 years of California biotech powering innovation, jobs, and life-changing breakthroughs across California.

[Biocom @Biocom]

The California State Senate adopted Senate Resolution 88 today, recognizing 50 years of modern biotechnology and the 20 years of the California Biotechnology Foundation.

California is the birthplace of modern biotech and life science is now the state's second largest industry, supporting 1M+ jobs and hundreds of billions in economic activity.

Thank you to @SenBlakespear and the Legislature for recognizing the scientists and innovators improving lives here and around the world.

Watch the ceremony: https://t.co/8CYxOEoQ0M

#Biotech #LifeSciences #CALeg

[California Biotech @CABiotech]

CBF was proud to be a part of this important meeting!

[California Rare Disease Access Coalition @CARareDisease]

Yesterday the Coalition hosted our 2nd meeting of 2026. Thanks to everyone who participated in the valuable discussion about barriers patient’s face to access and how we can work together to overcome those obstacles.

#raredisease #StrongerTogether

[California Biotech @CABiotech]

CBF is a proud member of the advisory board for @CARareDisease and was excited to join them at their first annual Rare Champions Reception!

[California Rare Disease Access Coalition @CARareDisease]

We were excited to host our first annual Rare Champions Reception last night!

Thank you to Assemblymember Rick Chavez Zbur - our Legislative Rare Disease Champion, Siri Vaeth - our Patient Advocacy Champion, Assemblyman Jeff Gonzalez and everyone who joined us.

#raredisease

[California Biotech @CABiotech]

Behind every breakthrough is leadership that fuels innovation. This #AAPIHeritageMonth, we spotlight Carolyn Ng, Partner at TPG Life Sciences Innovations and @biocom board member. https://t.co/Tb4WXJQejK

[California Biotech @CABiotech]

May is #LupusAwarenessMonth! 🟣 Lupus is a complex autoimmune disease affecting 1.5 million Americans — disproportionately women and people of color. CA biotech is advancing targeted therapies to help patients manage this unpredictable condition. Learn more: https://t.co/l3GL491FrZ

[California Biotech @CABiotech]

Driving innovation from lab to patient, Stacey Ma, PhD, is a leader shaping the future of biotech. This #AAPIHeritageMonth, we celebrate her impact as EVP of Pharmaceutical Development & Manufacturing at @GileadSciences. https://t.co/tL0MoX1WDs

[California Biotech @CABiotech]

A major milestone in gene therapy: the FDA just approved @Regeneron’s one-time treatment for inherited deafness—the first of its kind. In trials, many patients regained meaningful hearing, marking a new era in treating genetic conditions. 🔬 https://t.co/NDIHMgSn2j

[California Biotech @CABiotech]

This #AAPIHeritageMonth, we honor Dr. Howard Chang, SVP of Global Research and Chief Scientific Officer at @Amgen, for his pioneering leadership in advancing cutting-edge research and innovation across the biotech industry.

[California Biotech @CABiotech]

It's #HepatitisAwarenessMonth! 🧬 Hepatitis affects millions of Americans, yet many don't know they're infected. Early detection is key & biotech innovation is driving the next generation of treatments & diagnostics to end viral hepatitis. Learn more: https://t.co/flytKxHVvZ

[California Biotech @CABiotech]

Celebrating Arpit Davé this #AAPIHeritageMonth – EVP & Chief Digital and Information Officer at @BioMarin. His leadership in digital transformation and AI is helping shape the future of biotech innovation and patient care. https://t.co/cPXVKZoxZZ

[California Biotech @CABiotech]

Bringing new medicines to patients requires significant time, investment and scientific risk. Deloitte’s latest report shows pharma companies continue to increase R&D spending as they pursue the next generation of breakthrough therapies. https://t.co/kpmzUItHxx

[California Biotech @CABiotech]

Following its recent acquisition of @Amicus Therapeutics, @BioMarin will leverage its global scale, established commercial infrastructure and experience in rare disease to reach more patients living with Fabry and Pompe diseases around the world.

[California Biotech @CABiotech]

A major milestone for gene editing! @intelliatx's CRISPR-based therapy dramatically reduced swelling attacks in a Phase 3 trial for hereditary angioedema, putting it on a clear path to FDA approval. 🧬 Read more: https://t.co/AEHdoIkTHY #CRISPR #RareDisease

[California Biotech @CABiotech]

This #AAPIHeritageMonth, we’re recognizing Chinh Dang, Chief Information & Research Infrastructure Officer at @scrippsresearch, for advancing the technology & infrastructure powering groundbreaking biomedical research in California & beyond. https://t.co/CZe1FfBIT4

[California Biotech @CABiotech]

ICYMI: 50 years ago, @Genentech was founded in San Francisco and changed medicine forever. 🎉 From synthetic insulin to pioneering AI in drug development, CA biotech's trailblazer is still leading the way. more: https://t.co/NxlJKCIEGB #CABiotech #BiotechInnovation

[California Biotech @CABiotech]

@RevMedCo's daraxonrasib nearly doubled overall survival in a Phase 3 pancreatic cancer trial — a big step forward for CA biotech & patients 🧬 Read more: https://t.co/XiJC0gKe1e #CancerResearch #BiotechInnovation #PancreaticCancer

[California Biotech @CABiotech]

This #ParkinsonsAwarenessMonth, we highlight @AspenNeuro whose work focuses on using a patient’s own cells to create dopamine producing neurons. This approach could help change how Parkinson’s is treated. 🧠 Learn more: https://t.co/OzpuoyVhwo

[California Biotech @CABiotech]

Researchers at @UCSanDiego have developed a blood test that may predict dementia risk in women up to 25 years before symptoms appear. This offers a powerful new tool for early detection and prevention. 🧠 Read more: https://t.co/B7WTq25qCY

[California Biotech @CABiotech]

.@neurocrine is partnering with @CAC_Updates for a webinar on May 7th to elevate awareness of Tardive Dyskinesia in behavioral health care. Join clinicians, caregivers & advocates to discuss screening, early ID & better care practices: https://t.co/TS4x0DZXPK

[California Biotech @CABiotech]

.@UCLAHealth has launched a new clinical trial targeting recurrent prostate cancer, exploring an innovative treatment approach aimed at improving outcomes for patients with limited options. 🧬 Read more: https://t.co/60SiR87dGf

[California Biotech @CABiotech]

.@UCSF researchers have developed a way to generate cancer-fighting immune cells directly inside the body, a breakthrough that could simplify cell therapy and expand access to advanced cancer treatments. 🔬 Read more: https://t.co/OiFGxaZu5D